Neoplastic Syndromes, Hereditary

"Neoplastic Syndromes, Hereditary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance.

Descriptor ID	D009386
MeSH Number(s)	C04.700 C16.320.700
Concept/Terms	Neoplastic Syndromes, Hereditary Neoplastic Syndromes, Hereditary Hereditary Neoplastic Syndromes Hereditary Neoplastic Syndrome Neoplastic Syndrome, Hereditary Syndrome, Hereditary Neoplastic Syndromes, Hereditary Neoplastic Hereditary Cancer Syndromes Cancer Syndrome, Hereditary Hereditary Cancer Syndrome Syndrome, Hereditary Cancer Syndromes, Hereditary Cancer Cancer Syndromes, Hereditary

Below are MeSH descriptors whose meaning is more general than "Neoplastic Syndromes, Hereditary".

Diseases [C]
Neoplasms [C04]
Neoplastic Syndromes, Hereditary [C04.700]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Genetic Diseases, Inborn [C16.320]
Neoplastic Syndromes, Hereditary [C16.320.700]

Below are MeSH descriptors whose meaning is related to "Neoplastic Syndromes, Hereditary".

Below are MeSH descriptors whose meaning is more specific than "Neoplastic Syndromes, Hereditary".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neoplastic Syndromes, Hereditary" by people in this website by year, and whether "Neoplastic Syndromes, Hereditary" was a major or minor topic of these publications.

Bar chart showing 7 publications over 4 distinct years, with a maximum of 2 publications in 2016 and 2018 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2016	2	0	2
2018	2	0	2
2022	1	1	2

Below are the most recent publications written about "Neoplastic Syndromes, Hereditary" by people in Profiles.

Zeng C, Bastarache LA, Tao R, Venner E, Hebbring S, Andujar JD, Bland ST, Crosslin DR, Pratap S, Cooley A, Pacheco JA, Christensen KD, Perez E, Zawatsky CLB, Witkowski L, Zouk H, Weng C, Leppig KA, Sleiman PMA, Hakonarson H, Williams MS, Luo Y, Jarvik GP, Green RC, Chung WK, Gharavi AG, Lennon NJ, Rehm HL, Gibbs RA, Peterson JF, Roden DM, Wiesner GL, Denny JC. Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases. JAMA Oncol. 2022 06 01; 8(6):835-844.

View in: PubMed
Heinze K, Nazeran TM, Lee S, Kr?mer P, Cairns ES, Chiu DS, Leung SC, Kang EY, Meagher NS, Kennedy CJ, Boros J, Kommoss F, Vollert HW, Heitz F, du Bois A, Harter P, Grube M, Kraemer B, Staebler A, Kommoss FK, Heublein S, Sinn HP, Singh N, Laslavic A, Elishaev E, Olawaiye A, Moysich K, Modugno F, Sharma R, Brand AH, Harnett PR, DeFazio A, Fortner RT, Lubinski J, Lener M, Toloczko-Grabarek A, Cybulski C, Gronwald H, Gronwald J, Coulson P, El-Bahrawy MA, Jones ME, Schoemaker MJ, Swerdlow AJ, Gorringe KL, Campbell I, Cook L, Gayther SA, Carney ME, Shvetsov YB, Hernandez BY, Wilkens LR, Goodman MT, Mateoiu C, Linder A, Sundfeldt K, Kelemen LE, Gentry-Maharaj A, Widschwendter M, Menon U, Bolton KL, Alsop J, Shah M, Jimenez-Linan M, Pharoah PD, Brenton JD, Cushing-Haugen KL, Harris HR, Doherty JA, Gilks B, Ghatage P, Huntsman DG, Nelson GS, Tinker AV, Lee CH, Goode EL, Nelson BH, Ramus SJ, Kommoss S, Talhouk A, K?bel M, Anglesio MS. Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. J Pathol. 2022 04; 256(4):388-401.

View in: PubMed
Piccolo V, Russo T, Moscarella E, Brancaccio G, Alfano R, Argenziano G. Dermatoscopy of Vascular Lesions. Dermatol Clin. 2018 Oct; 36(4):389-395.

View in: PubMed
Slavin TP, Neuhausen SL, Nehoray B, Niell-Swiller M, Solomon I, Rybak C, Blazer K, Adamson A, Yang K, Sand S, Guerrero-Llamas N, Castillo D, Herzog J, Wu X, Tao S, Raja S, Chung V, Singh G, Nadesan S, Brown S, Cruz-Correa M, Petersen GM, Weitzel J. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Fam Cancer. 2018 04; 17(2):235-245.

View in: PubMed
Cruz-Correa M, P?rez-Mayoral J, Dutil J, Echenique M, Mosquera R, Rivera-Rom?n K, Umpierre S, Rodriguez-Quilichini S, Gonzalez-Pons M, Olivera MI, Pardo S. Clinical Cancer Genetics Disparities among Latinos. J Genet Couns. 2017 Jun; 26(3):379-386.

View in: PubMed
Ransohoff KJ, Jaju PD, Jaju PD, Tang JY, Carbone M, Leachman S, Sarin KY. Familial skin cancer syndromes: Increased melanoma risk. J Am Acad Dermatol. 2016 Mar; 74(3):423-34; quiz 435-6.

View in: PubMed
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005 Apr 27; 293(16):1979-85.

View in: PubMed
Bianco C, Brittenham G, Gilcher RO, Gordeuk VR, Kushner JP, Sayers M, Chambers L, Counts RB, Aylesworth C, Nemo G, Alving B. Maintaining iron balance in women blood donors of childbearing age: summary of a workshop. Transfusion. 2002 Jun; 42(6):798-805.

View in: PubMed

People

Explore

Similar Concepts

Top Journals